viernes, 29 de noviembre de 2024

It might be now or never for the BIOSECURE Act Sen. Rand Paul’s new role could make it harder to target Chinese biotech firms

https://www.statnews.com/2024/11/27/biosecure-act-china-biotech-wuxi-status-chance-of-passing/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-8qI3Iq5ht3MsDggbUxEjWqlUlH_CovV6ftv_IyUsXOkGusJl1EUOOqQ0NPxCX33BpLOrCKdZU7GblQcWyaVIDd1g2fkA&_hsmi=336007103&utm_content=336007103&utm_source=hs_email

No hay comentarios: